Maplight Therapeutics, Inc. · NASDAQ:MPLT
Novo Holdings A/S reported a 4.90% stake in Maplight Therapeutics, Inc. (Schedule 13D/A)
Event Jul 30, 2026 · Filed Jul 31, 2026
Novo Holdings A/S reported a 4.90% stake in Maplight Therapeutics, Inc., 2,086,622 shares, with active intent on Jul 30, 2026. Filed Jul 31, 2026 (Schedule 13D/A).
- Stake
- 4.90%
- Shares
- 2,086,622
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Novo Holdings A/S | 4.90% | 2,086,622 |
Source
Related
- Maplight Therapeutics, Inc.
- Novo Holdings A/S
- Maplight Therapeutics, Inc. shareholders
- Schedule 13D · Novo Holdings A/S · Nov 4, 2025
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026